SUBSCRIBE
SUBSCRIBE
News   FDA

Mallinckrodt Inc. Painkiller Gets FDA OK

November 2, 2009 | 
1 min read
St. Louis Business Journal -- A generic painkiller developed by Covidien’s pharmaceutical subsidiary, Mallinckrodt Inc., has received approval from the U.S. Food and Drug Administration.
FDA Approvals
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
man pulling each of the opposite ends of a rope in black and white, on a blue background with some blank space on top
Obesity
Novo, Lilly Jostle For Market Lead in Obesity With New Regulatory Efforts
September 16, 2025
 · 
2 min read
 · 
Tristan Manalac
Hanging questions.Blue background.
Adcomms
FDA Flip-Flops on Scrapping Adcomms
September 15, 2025
 · 
2 min read
 · 
Tristan Manalac
A scientist with pill bottles in front of FDA headquarters
FDA
FDA Action Alert: Merck, Sanofi, Biogen and More
September 15, 2025
 · 
6 min read
 · 
Tristan Manalac
Crisis. Sanctions. Withdrawal of investment and capital. Stop participation. The collapse of the company, the split of business partners.
Autoimmune disease
Intercept Withdraws Embattled Liver Drug from US Market
September 12, 2025
 · 
2 min read
 · 
Tristan Manalac